Crossmark

10 Years After EPISCAN: A New Study on the Prevalence of COPD in Spain—A Summary of the EPISCAN II Protocol

Crossref DOI link: https://doi.org/10.1016/j.arbr.2018.11.008

Published Print: 2019-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Alfageme, Inmaculada

de Lucas, Pilar

Ancochea, Julio

Miravitlles, Marc

Soler-Cataluña, Juan José

García-Río, Francisco

Casanova, Ciro

Rodríguez González-Moro, José Miguel

Cosío, Borja G.

Sánchez, Guadalupe

Soriano, Joan B.
Funding

Funding for this research was provided by:

GlaxoSmithKline España (205932, NCT03028207)

GlaxoSmithKline Australia
License Information

Text and Data Mining valid from 2019-01-01
More Information

This article is maintained by: Elsevier

Article Title: 10 Years After EPISCAN: A New Study on the Prevalence of COPD in Spain—A Summary of the EPISCAN II Protocol

Journal Title: Archivos de Bronconeumología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.arbr.2018.11.008

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.arbres.2018.05.011

Content Type: article

Copyright: © 2018 SEPAR. Published by Elsevier España, S.L.U. All rights reserved.